Onconetix, Inc. (ONCO)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Commercial	2.52M	58.47K	-	-	-
Commercial Growth	4217.31%	-	-	-	-
Total	2.52M	58.47K	-	-	-
Total Growth	4217.31%	-	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Non-European Union	23.84K	-	-	-	-
United States	63.12K	-	-	-	-
Switzerland	2.44M	58.47K	-	-	-
Switzerland Growth	4068.58%	-	-	-	-
Total	2.52M	58.47K	-	-	-
Total Growth	4217.31%	-	-	-	-

Source: S&P Global Market Intelligence.